News
ONWRY
3.150
NaN%
--
Onward Medical N.V. reports 1H results
Seeking Alpha · 4d ago
ONWARD Medical Reports First Half 2026 Results with Strong Product Revenue Growth and Continued Progress across ARC Therapy Pipeline
Barchart · 5d ago
ONWARD Medical Announces First Implant in New Clinical Feasibility Study Evaluating ARC-IM System to Restore Mobility After Spinal Cord Injury
Barchart · 09/03 00:30
ONWARD Medical Reports First Quarter 2026 Results with Strong Commercial Momentum and Key Clinical Milestones
Barchart · 05/26 00:30
ONWARD Medical to Announce First Quarter 2026 Results on May 26, 2026
Barchart · 05/19 00:30
ONWARD Medical Announces Results of the 2026 Annual General Meeting of Shareholders
Barchart · 05/13 10:57
ONWARD Medical Publishes Closing of Bookbuild Offering
Barchart · 04/20 10:45
ONWARD Medical Successfully Raises over EUR 40 Million in Capital Increase
Barchart · 04/16 00:30
ONWARD Medical Launches Capital Increase for Indicative Amount of EUR 40 Million
Barchart · 04/15 11:19
ONWARD Medical Publishes Convocation of the 2026 Annual General Meeting of Shareholders and Proposed Resolutions
Barchart · 04/01 01:45
ONWARD Medical Schedules Webcast to Report Full-Year 2025 Financial Results and Provide Business Update
Barchart · 03/23 01:30
ONWARD Medical Announces First Participant Enrolled in Global Pivotal Study Evaluating ARC-IM System to Address Blood Pressure Instability After Spinal Cord Injury
Barchart · 02/04 00:30
ONWARD Medical Completes Two Additional Brain-Computer Interface Implants Paired with Spinal Cord Stimulation Technology to Restore Thought-Driven Movement
Barchart · 01/22 00:30
ONWARD Medical Drives Strong US ARC-EX Adoption and Achieves Important Scientific and Regulatory Milestones in Q3 2025
Barchart · 11/24/2025 00:30
ONWARD Medical Publishes Closing of Bookbuild Offering
Barchart · 10/28/2025 11:45
ONWARD Medical Successfully Raises Over EUR 50 Million in Capital Increase
Barchart · 10/24/2025 00:30
ONWARD Medical Launches Capital Increase for Indicative Amount of EUR 50 Million
Barchart · 10/22/2025 10:49
ONWARD Medical Provides Preliminary Q3 2025 Update Highlighting Accelerating ARC-EX Adoption in the United States
Barchart · 10/13/2025 00:30
Portzamparc – BNP Paribas Group Initiates Coverage of ONWARD Medical with a Buy Rating and Target Price of EUR 10.20
Barchart · 10/08/2025 00:30
Concurrent Publications in Nature and Nature Medicine Highlight Advances in Blood Pressure Regulation after Spinal Cord Injury Using ONWARD ARC-IM Therapy
Barchart · 09/18/2025 00:30
More
Webull provides a variety of real-time ONWRY stock news. You can receive the latest news about ONWARD Medical NV through multiple platforms. This information may help you make smarter investment decisions.
About ONWRY
Onward Medical NV, formerly known as GTX Medical BV, is a medical technology company based in the Netherlands. The Company is primarily engaged in developing and commercializing innovative therapies to enable functional recovery for people with spinal cord injury. It develops two technology platforms ARC EX and ARC IM.